Clinical relevance of mechanisms of antifungal drug resistance in yeasts.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Enfermedades Infecciosas y Microbiologia Clinica

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0213-005X(02)72842-5PMID 12425880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections.

  2002cited by this paper
• Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

  2002cited by this paper
• Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.

  2002cited by this paper
• Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

  2001cited by this paper
• The Evolution of Candida Species and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)-Seropositive and At-Risk HIV-Seronegative Women.

  2001cited by this paper
• Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans

  2001cited by this paper
• Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

  2001cited by this paper
• The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

  2001cited by this paper
• Genomic Profiling of the Response of Candida albicans to Itraconazole Treatment Using a DNA Microarray

  2001cited by this paper
• Improved Detection of Amphotericin B-Resistant Isolates of Candida lusitaniae by Etest

  2001cited by this paper
• Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata

  2001cited by this paper
• In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

  2000cited by this paper
• In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.

  2000cited by this paper
• In Vitro Activities of Ravuconazole (BMS-207147) against 541 Clinical Isolates of Cryptococcus neoformans

  2000cited by this paper
• In Vitro Susceptibility of Environmental Cryptococcus neoformans Variety neoformans Isolates from Turkey to Six Antifungal Agents, Including SCH56592 and Voriconazole

  2000cited by this paper
• Sequence Analysis of ARI-1, a Novel OXA β-Lactamase, Responsible for Imipenem Resistance inAcinetobacter baumannii 6B92

  2000cited by this paper
• The ATP Binding Cassette Transporter GeneCgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents

  1999cited by this paper
• Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.

  1999cited by this paper
• In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.

  1999cited by this paper
• Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans.

  1999cited by this paper
• Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development.

  1998cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• Importance of Candida species other than Candida albicans as opportunistic pathogens.

  1998cited by this paper
• In Vitro Susceptibilities of CandidaBloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and Voriconazole

  1998cited by this paper
• Rapid, Transient Fluconazole Resistance inCandida albicans Is Associated with Increased mRNA Levels of CDR

  1998cited by this paper
• Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.

  1998cited by this paper
• Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

  1998cited by this paper
• Molecular biological characterization of an azole-resistant Candida glabrata isolate

  1997cited by this paper
• Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

  1997cited by this paper
• Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

  1997cited by this paper
• Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora

  1997cited by this paper
• In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents

  1997cited by this paper
• In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)

  1997cited by this paper
• Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors

  1996cited by this paper
• Detection of amphotericin B-resistant Candida isolates in a broth-based system

  1995cited by this paper
• Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients

  1995cited by this paper
• Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

  1995cited by this paper
• Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.

  1994cited by this paper
• A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

  1994cited by this paper
• Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient.

  1994cited by this paper
• A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

  1994cited by this paper
• Mode of Action Studies

  1990cited by this paper
• Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

  1990cited by this paper
• Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals.

  1990cited by this paper
• Amphotericin B-induced oxidative damage and killing of Candida albicans.

  1986influential reference
• Incidence of polyene-resistant yeasts recovered from clinical specimens

  1980cited by this paper
• Candida Albicans

  1964cited by this paper

• In Vitro Activities of Five Antifungal Drugs Against Conidia and Sclerotic Cells of Chromoblastomycosis Agent Fonsecaea spp

  2025cites this paper
• In Vitro Antifungal Activity of The Flavonoid extracts from Rhamnus alaternus L. (Rhamnaceae).

  2022cites this paper
• A Review: Efficacy of Some Natural Compounds as Antifungal Agents

  2022cites this paper
• New strategies for combating fungal infections: Inhibiting inositol lipid signaling by targeting Sec14 phosphatidylinositol transfer proteins.

  2022cites this paper
• Sensibilidad y resistencia in vitro frente al fluconazol de cepas del complejo Candida glabrata aisladas de procesos infecciosos vaginales

  2021cites this paper
• Pharmacological Efficacy of Tamarix aphylla: A Comprehensive Review

  2021cites this paper
• Medicinal Plants Having Antifungal Properties

  2020cites this paper
• Modelling and molecular docking studies of the cytoplasmic domain of Wsc-family, full-length Ras2p, and therapeutic antifungal compounds

  2019cites this paper
• Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model

  2018cites this paper
• Identification of Candida Species Using PCR/RFLP and Evaluation of ERG-11 Gene Expression in Neonatal and Pediatric ICUs

  2018cites this paper
• Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment

  2018cites this paper
• Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata

  2017cites this paper
• Glabridin induces overexpression of two major apoptotic genes, MCA1 and NUC1, in Candida albicans.

  2017cites this paper
• Caractérisations génotypique et phénotypique de souches de Candida glabrata développant des résistances aux antifongiques

  2017cites this paper
• Synergic effect of combination of glycyrol and fluconazole against experimental cutaneous candidiasis due to Candida albicans

  2016cites this paper
• β-lactam substituted polycyclic fused pyrrolidine/pyrrolizidine derivatives eradicate C. albicans in an ex vivo human dentinal tubule model by inhibiting sterol 14-α demethylase and cAMP pathway.

  2016cites this paper
• Synergic effect of combination of glycyrol and fluconazole against experimental cutaneous candidiasis due to Candida albicans

  2016cites this paper
• Developing genetic tools to exploit Chaetomium thermophilum for biochemical analyses of eukaryotic macromolecular assemblies

  2016cites this paper
• Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients

  2016cites this paper
• Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital

  2016cites this paper
• Use of phylogenetical analysis to predict susceptibility of pathogenic Candida spp. to antifungal drugs.

  2016cites this paper
• Selected mechanisms of molecular resistance of Candida albicans to azole drugs.

  2015cites this paper
• P-gp Inhibitory Activity from Marine Sponges, Tunicates and Algae

  2015cites this paper
• Candiduria among HIV- Infected Patients Attending a Tertiary Hospital in Benin City

  2014cites this paper
• Perfil de susceptibilidad a anti fúngicos de aislados de Candida spp por el método de microdilución. Nuevos puntos de cortes para fluconazol Anti-fungal susceptibility profile of Candida spp isolates by the microdilution method. New cutoff points for fluconazole

  2014cites this paper
• Masking of β(1-3)-Glucan in the Cell Wall of Candida albicans from Detection by Innate Immune Cells Depends on Phosphatidylserine

  2014cites this paper
• Phosphatidylserine Immune Cells Depends on Candida albicans from Detection by Innate ( 1-3 )-Glucan in the Cell Wall of β Masking of

  2014cites this paper
• Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.

  2014cites this paper
• Antifungal and cytotoxicity activities of the fresh xylem sap of Hymenaea courbaril L. and its major constituent fisetin

  2014cites this paper
• Erg 11 mutations associated with azole resistance in clinical isolates of Candida albicans Running title : Erg 11 mutations in Candida albicans

  2013cites this paper
• Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.

  2013cites this paper
• Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin.

  2013cites this paper
• [Mechanisms of yeast resistance to environmental stress].

  2013cites this paper
• Isolation of Metabolites and Screening for Antimicrobial Activity of Calodendrum Capense Thunb. (Rutaceae).

  2013cites this paper
• Perfil de suscetibilidade in vitro e caracterização molecular de leveduras do gênero Candida isoladas de pacientes com vulvovaginite

  2013cites this paper
• Estudio in vitro de antimicóticos contra cepas de Candida aisladas de pacientes del Hospital General de México OD

  2012cites this paper
• Perfil fenotípico, diferenciação molecular, produção de enzimas e sensibilidade aos antifúngicos de amostras de leveduras isoladas em três grupos amostrais: mulheres assintomáticas, com candidíase vulvovaginal primária e recorrente

  2012cites this paper
• Antifungals in Systemic Neonatal Candidiasis

  2012cites this paper
• Autophagy in Plasmodium falciparum intraerythrocytic stages

  2012cites this paper
• Host-Fungal Interactions: Pathogenicity versus Immunity

  2012influential citation
• Antifungal Resistance and New Strategies to Control Fungal Infections

  2011cites this paper
• Antifungal activity of novel synthetic peptides by accumulation of reactive oxygen species (ROS) and disruption of cell wall against Candida albicans.

  2011cites this paper
• Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis

  2011cites this paper
• Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance

  2011cites this paper
• Les pompes à efflux en mycologie médicale: mécanismes moléculaires et perspectives thérapeutiques

  2010cites this paper
• A systems biology approach to the mutual interaction between yeast and the immune system.

  2010cites this paper
• Treatment of neonatal fungal infections.

  2010cites this paper
• Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis.

  2010cites this paper
• Gene Expression and Identification Related to Fluconazole Resistance of Candida glabrata Strains

  2010cites this paper
• Mutants with heteroresistance to amphotericin B and fluconazole in Candida

  2009cites this paper
• Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth

  2009cites this paper
• SUSCETIBILIDADE IN VITRO DE Cryptococcus neoformans E Cryptococcus gattii FRENTE A DROGAS ANTIFÚNGICAS PELA CITOMETRIA DE FLUXO

  2009cites this paper
• Avaliação do fenômeno de heteroresistência em isolados clínicos de Cryptococcus neoformans

  2009influential citation
• Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.

  2009cites this paper
• Candida albicans-macrophage interactions: genomic and proteomic insights.

  2008cites this paper
• Mécanismes moléculaires de la résistance aux antifongiques chez candida glabrata

  2008cites this paper
• Specific chromosome alterations of Candida albicans: mechanisms for adaptation to pathogenicity.

  2008cites this paper
• Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.

  2007cites this paper
• Characterization of the RNA binding energetics of the Candida albicans poly(A) polymerase

  2007cites this paper
• Integrated Proteomics and Genomics Strategies Bring New Insight into Candida albicans Response upon Macrophage Interaction*S

  2007cites this paper
• AVALIAÇÃO DA CRIPTOCOCOSE EXPERIMENTAL SISTÊMICA EM CAMUNDONGOS BALB/c E TERAPÊUTICA COM ANFOTERICINA B, FLUCONAZOL E ASSOCIAÇÃO.

  2007cites this paper
• In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast Candida albicans

  2006cites this paper
• Biological, Biochemical, and Molecular Characterization of a New Clinical Trichophyton rubrum Isolate Resistant to Terbinafine

  2006cites this paper
• Currently used antimycotics: spectrum, mode of action and resistance occurrence.

  2005cites this paper
• Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis

  2005cites this paper
• Berberine synergy with amphotericin B against disseminated candidiasis in mice.

  2005cites this paper
• Determinación de la actividad antifúngica contra Candida albicans y Aspergillus niger de 10 plantas medicinales de 3 departamentos del Perú

  2005cites this paper
• Neonatal candidiasis: prophylaxis and treatment

  2005cites this paper
• cDNA array analysis of the differential expression change in virulence-related genes during the development of resistance in Candida albicans.

  2005cites this paper
• The Functional Basis of Mycophenolic Acid Resistance in Candida albicans IMP Dehydrogenase*

  2005cites this paper
• Zinc eluted from siliconized latex urinary catheters does not affect the in vitro activity of antifungal agents against Candida spp.

  2005cites this paper
• Fluconazole resistance in Candida albicans: a review of mechanisms.

  2004cites this paper
• Diagnostic Value of Signs and Symptoms of Mammary Candidosis among Lactating Women

  2004cites this paper
• Molecular Mechanism of Terbinafine Resistance in Saccharomyces cerevisiae

  2003cites this paper
• Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9alpha,11alpha-epoxycholest-7-ene-3beta,5alpha,6alpha,19-tetrol 6-acetate.

  2003cites this paper
• [Systemic antifungal agents].

  2003cites this paper
• Fungal Cell Wall Septation and Cytokinesis Are Inhibited by Bleomycins

  2003cites this paper
• Saccharomyces cerevisiae Resistance in Molecular Mechanism of Terbinafine

  2003cites this paper
• Antifúngicos de uso sistémico

  2003cites this paper
• Current awareness on yeast.

  2003cites this paper
• Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos

  2002cites this paper
• [Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].

  2002cites this paper